C

Cabio Biotech Wuhan Co Ltd
SSE:688089

Watchlist Manager
Cabio Biotech Wuhan Co Ltd
SSE:688089
Watchlist
Price: 22.82 CNY -1.38%
Market Cap: 3.8B CNY

Cabio Biotech Wuhan Co Ltd
Total Liabilities & Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Cabio Biotech Wuhan Co Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
C
Cabio Biotech Wuhan Co Ltd
SSE:688089
Total Liabilities & Equity
ÂĄ1.7B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Shanghai Putailai New Energy Technology Co Ltd
SSE:603659
Total Liabilities & Equity
ÂĄ46B
CAGR 3-Years
13%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Wanhua Chemical Group Co Ltd
SSE:600309
Total Liabilities & Equity
ÂĄ328.3B
CAGR 3-Years
15%
CAGR 5-Years
21%
CAGR 10-Years
22%
Hoshine Silicon Industry Co Ltd
SSE:603260
Total Liabilities & Equity
ÂĄ86.1B
CAGR 3-Years
24%
CAGR 5-Years
36%
CAGR 10-Years
N/A
C
CNGR Advanced Material Co Ltd
SZSE:300919
Total Liabilities & Equity
ÂĄ73B
CAGR 3-Years
37%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Tianqi Lithium Corp
SZSE:002466
Total Liabilities & Equity
ÂĄ73.6B
CAGR 3-Years
5%
CAGR 5-Years
12%
CAGR 10-Years
26%
No Stocks Found

Cabio Biotech Wuhan Co Ltd
Glance View

Market Cap
3.8B CNY
Industry
Chemicals

Cabio Biotech Wuhan Co Ltd is a China-based company principally engaged in biotechnology business. The Company is mainly engaged in the research and development, production and sales of polyunsaturated fatty acids arachidonic acid (ARA), algal oil docosahexaenoic acid (DHA) and sialic acid (SA), and natural beta-carotene products. Its products are mainly used in infant formula food, dietary supplements, nutritional health food and formula food for special medical purposes. The Company integrates industrial strain-oriented optimization technology, fermentation fine control technology, and efficient separation, purification and preparation technology, and provides nutrient products and innovative solutions for customers in the global nutrition and health field through sustainable microbial synthesis and manufacturing methods. The Company mainly conducts its business in domestic and overseas markets.

Intrinsic Value
29.52 CNY
Undervaluation 23%
Intrinsic Value
Price
C

See Also

What is Cabio Biotech Wuhan Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
1.7B CNY

Based on the financial report for Dec 31, 2024, Cabio Biotech Wuhan Co Ltd's Total Liabilities & Equity amounts to 1.7B CNY.

What is Cabio Biotech Wuhan Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
5%

Over the last year, the Total Liabilities & Equity growth was 5%. The average annual Total Liabilities & Equity growth rates for Cabio Biotech Wuhan Co Ltd have been 5% over the past three years , 5% over the past five years .

Back to Top